1. Home
  2. PL vs JAZZ Comparison

PL vs JAZZ Comparison

Compare PL & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$34.66

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$194.37

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
JAZZ
Founded
2010
2003
Country
United States
Ireland
Employees
970
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
10.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PL
JAZZ
Price
$34.66
$194.37
Analyst Decision
Buy
Strong Buy
Analyst Count
13
13
Target Price
$24.34
$216.92
AVG Volume (30 Days)
15.7M
717.3K
Earning Date
03-19-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,618,693,000.00
Revenue This Year
$41.85
$6.13
Revenue Next Year
$29.44
$7.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.92
$98.96
52 Week High
$38.21
$200.24

Technical Indicators

Market Signals
Indicator
PL
JAZZ
Relative Strength Index (RSI) 59.55 62.56
Support Level $5.84 $159.78
Resistance Level $37.05 $198.00
Average True Range (ATR) 3.67 4.92
MACD 0.25 0.83
Stochastic Oscillator 71.28 72.14

Price Performance

Historical Comparison
PL
JAZZ

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: